Form 4/A for MAIA MAIA Biotechnology, Inc.
Accepted 2022-11-23 00:00:00 ET · period of report 2022-08-01 · accession 0001127602-22-026326 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2022-11-23 | 2022-08-01 | MAIA | Vitoc Vlad | CEO, Dir, 10% | P - Purchase | $5.00 | +6,000 | 789.1K | +0.8% | +$30.0K |
| AI | 2022-11-23 | 2022-08-01 | MAIA | Vitoc Vlad | CEO, Dir, 10% | P - Purchase | $5.00 | +10.0K | 210.0K | +5% | +$50.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-01 | P | A | 6,000 | $5.00 | 789,121 | D See Footnote | — | — | (F2) These securities are beneficially owned by Mr. Vitoc's spouse. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
| 2 | Common | Common Stock | 2022-08-01 | P | A | 10,000 | $5.00 | 210,000 | I | — | — |